Profil
Laura Saward formerly worked at Cangene Corp., as Chief Scientific Officer from 2012 to 2014, Emergent BioSolutions, Inc., as SVP & Antibody Therapeutics Business Unit from 2017 to 2021, and Manitoba Health Research Council, as Member.
Dr. Saward received her undergraduate degree from the University of Guelph and doctorate degree from the University of Manitoba.
Anciens postes connus de Laura Saward
| Sociétés | Poste | Fin |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/10/2021 |
| CANGENE CORPORATION | Chief Tech/Sci/R&D Officer | 01/04/2014 |
| Manitoba Health Research Council | Corporate Officer/Principal | - |
Formation de Laura Saward
| University of Guelph | Undergraduate Degree |
| University of Manitoba | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
| Manitoba Health Research Council |
